Glycated haemoglobin testing, commonly known as HbA1c testing, plays a pivotal role in diabetes management by providing a long-term indicator of average blood glucose levels over the previous two to three months. This non-invasive assay is employed in clinical laboratories, point-of-care settings, and even home testing kits, offering fast turnaround times and reliable results. Key advantages include enhanced patient compliance, streamlined care pathways, and reduced risk of diabetes-related complications through timely therapeutic adjustments.

As health systems worldwide aim to curb the rising incidence of type 1 and type 2 diabetes, demand for precise glycemic monitoring tools has surged, driving ongoing innovation in assay sensitivity, calibration protocols, and data connectivity features. Glycated Haemoglobin Testing Market indicates strong uptake of both automated laboratory analyzers and portable devices, with integrated software solutions facilitating remote monitoring and telehealth initiatives. Robust reimbursement policies in developed regions further underpin market growth, while emerging economies present significant opportunities for expanding diagnostic infrastructure.

The glycated haemoglobin testing market is estimated to be valued at USD 260.0 Mn in 2025 and is expected to reach USD 469.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

Key Takeaways
Key players operating in the Glycated Haemoglobin Testing Market are Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Tosoh Corporation and Bio-Rad Laboratories.

These market companies command substantial market share through ongoing product launches, strategic alliances, and extensive distribution networks. For instance, Roche Diagnostics leverages its cobas platform for high-throughput laboratory testing, while Abbott Laboratories focuses on point-of-care instruments like the Afinion™ 2 analyzer. Siemens Healthineers emphasizes automation and digital connectivity, enhancing workflow efficiency for clinical laboratories. Tosoh Corporation and Bio-Rad Laboratories continue to bolster their foothold via specialized assays and calibration kits, addressing strict regulatory standards under organizations such as NGSP and IFCC. Collectively, these industry leaders shape market dynamics by investing in R&D and expanding their service portfolios.

‣ Get more insights on : Glycated Haemoglobin Testing Market

‣ Get this Report in Japanese Language: グリコヘモグロビン検査市場

‣ Get this Report in Korean Language:   당화혈색소검사시장